Can a tech company from Ahmedabad become the secret weapon of pharma giants?
That’s exactly what Dev IT just proved.
In a big win for this homegrown IT firm, Dev IT has secured a ₹4.4 crore order from Alivus Lifesciences (formerly Glenmark Life Sciences), a major player in the pharma world.
This is not just another deal. It shows how trusted Dev IT has become when it comes to solving complex IT problems for big companies.
The Real Deal: ₹3.60 Crore for Microsoft Licensing
According to a stock exchange filing, the biggest slice of the deal—worth ₹3.60 crore—is for Microsoft Select Plus perpetual licenses. While the actual billing will be handled by Microsoft’s Licensing Solution Partner, Dev IT played the key advisory role here.
They didn’t just sell a license. They helped Alivus Lifesciences align its entire IT setup with the right Microsoft licensing model.
That’s deep, technical work. And it shows how Dev IT is becoming a go-to advisor for digital transformation in India’s enterprise sector.
Also Read Bajaj Finance Q1: Deposits Jump 15% to ₹72,100 Cr, Stock Up 2%
₹80 Lakh More: Multi-Product IT Solutions
On top of the license advisory, Dev IT also got a direct order worth ₹80 lakh from Alivus Lifesciences. This includes a mix of Microsoft, Zoho, Adobe, and TeamViewer software.
This part is important. It shows Dev IT’s strength in giving custom solutions—not just pushing one brand, but stitching together different products that actually work for the client.
This move also confirms one thing: companies now want tech partners who solve problems, not just push products.
Why This Matters: A New Kind of Power Play
Alivus is not just any pharma company. It develops high-value APIs for serious health conditions like diabetes, cardiovascular issues, and neurological diseases. So, the stakes are high. They can’t afford mistakes in IT or digital operations.
That’s why this win is so powerful for Dev IT.
In India’s crowded tech market, winning trust at this level means one thing: you know your stuff.
Also Read Tata Power Reports 416% Jump in Rooftop Solar Installations in Q1 FY26
